<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-NMC-2673</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2673</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Нелинейные главные компоненты цитокинового профиля у детей с внебольничной пневмонией</article-title><trans-title-group xml:lang="en"><trans-title>Nonlinear main components of the cytokine profile in children with community-acquired pneumonia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0049-2194</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Изюрова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Iziurova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Изюрова Наталья Владимировна – ассистент кафедры пропедевтики детских болезней и педиатрии.</p><p>454092, Челябинск, ул. Воровского, 64</p><p>Тел.: 8 (963) 081-46-78</p></bio><bio xml:lang="en"><p>Natalia V. Iziurova - Assistant Professor, Department of Propaedeutics of Children’s Diseases and Pediatrics, South Ural Medical State University.</p><p>64 Vorovsky St Chelyabinsk 454092</p><p>Phone: +7 (963) 081-46-78</p></bio><email xlink:type="simple">Natusaz@live.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4920-2338</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нохрин</surname><given-names>Д. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Nokhrin</surname><given-names>D. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>К.б.н, доцент кафедры микробиологии, иммунологии и общей биологии биологического факультета.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>PhD (Biology), Associate Professor, Department of Microbiology, Immunology and General Biology, Faculty of Biology, Chelyabinsk State University.</p><p>Chelyabinsk</p></bio><email xlink:type="simple">nokhrin8@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0536-0924</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савочкина</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Savochkina</surname><given-names>A. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Д.м.н., профессор кафедры микробиологии, вирусологии и иммунологии.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Department of Microbiology, Virology and Immunology, South Ural Medical State University.</p><p>Chelyabinsk</p></bio><email xlink:type="simple">alina7423@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2367-875X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Узунова</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Uzunova</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Д.м.н., профессор, заведующий кафедрой пропедевтики детских болезней и педиатрии.</p><p>Челябинск</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head, Department of Propaedeutics of Children’s Diseases and Pediatrics, South Ural Medical State University.</p><p>Chelyabinsk</p></bio><email xlink:type="simple">propeddet@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural Medical State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Челябинский государственный университет»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chelyabinsk State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>13</day><month>06</month><year>2023</year></pub-date><volume>26</volume><issue>2</issue><fpage>337</fpage><lpage>344</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Изюрова Н.В., Нохрин Д.Ю., Савочкина А.Ю., Узунова А.Н., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Изюрова Н.В., Нохрин Д.Ю., Савочкина А.Ю., Узунова А.Н.</copyright-holder><copyright-holder xml:lang="en">Iziurova N.V., Nokhrin D.Y., Savochkina A.Y., Uzunova A.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2673">https://www.mimmun.ru/mimmun/article/view/2673</self-uri><abstract><p>Цитокины являются важнейшими медиаторами, которые контролируют и регулируют иммунные и воспалительные реакции через сложные сети и служат биомаркерами многих заболеваний. Количественное определение цитокинов помогает в определении иммунного статуса пациента и корректировке терапии при различных воспалительных заболеваниях, таких как сепсис, пневмония. Поскольку внебольничная пневмония остается распространенной причиной детской заболеваемости и смертности, прогноз тяжести заболевания у детей являются актуальной проблемой на современном этапе. Целью исследования было выявление ассоциаций между цитокинами у здоровых детей и у детей с внебольничной пневмонией (ВП) в зависимости от возраста пациентов и тяжести патологического процесса. Работа проведена на кафедре микробиологии, вирусологии и иммунологии, кафедре пропедевтики детских болезней и педиатрии и в НИИ иммунологии ФГБОУ ВО «Южно-Уральский государственный медицинский университет» Министерства здравоохранения Российской Федерации. В исследование вошли 117 детей в возрасте от 1 года до 18 лет с рентгенологически подтвержденным диагнозом внебольничной пневмонии тяжелой и нетяжелой. Группа сравнения сформирована из 28 здоровых детей, не имеющих на момент обследования внебольничной пневмонии, а также других признаков острой респираторной вирусной инфекции и не состоящих на диспансерном наблюдении по поводу какой-либо хронической патологии. Были определены уровни IL-1β, IFNγ, IL-6, IL-4, IL-10, IL-2, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF в сыворотке крови с помощью тест-систем, основанных на «сэндвич»-методе твердофазного ИФА с применением пероксидазы в качестве индикаторного фермента. Для статистического анализа использовали многомерный метод – нелинейный анализ главных компонент по алгоритму CATPCA. Проведенное исследование позволило обнаружить согласованное увеличение в сыворотке крови у детей с ВП IL-1β, IL-4, IL-10, IL-2, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF, причем наибольшую корреляцию с тяжестью показали IFNλ2 (IL-28A), IFNλ3 (IL-28B) и MCP-1, которые могут рассматриваться дополнительными биомаркерами тяжести внебольничной пневмонии. Также была обнаружена существенная вариабельность цитокинового профиля у здоровых детей и ее существенное сужение при пневмониях, особенно тяжелой.</p></abstract><trans-abstract xml:lang="en"><p>Cytokines are the key mediators which control and regulate immune and inflammatory responses via complex networks and serve as biomarkers of many diseases. Quantitative determination of cytokines is helpful in assessing immune status and adjusting therapy for various inflammatory diseases, such as sepsis and pneumonia. Since community-acquired pneumonia remains a common cause of childhood morbidity and mortality. At the present stage, prognosis of the disease severity in children is an urgent problem. The aim of our study was to identify associations between cytokine levels in healthy children and in children with community-acquired pneumonia (CAP), depending on the age of patients and severity of the pathological process. The work was carried out at the Department of Microbiology, Virology and Immunology, Department of Propaedeutics of Childhood Diseases and Pediatrics, and at the Research Institute of Immunology at the South Ural State Medical University. The study included 117 children aged 1 to 18 years with radiologically confirmed diagnosis of CAP, either severe or mild degree. The comparison group was composed from 28 healthy children who did not have community-acquired pneumonia, as well as other signs of acute respiratory viral infection at the time of examination, being observed for any chronic disorders. The levels of IL-1β, IFNγ, IL-6, IL-4, IL-10, IL-2, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF were determined in blood serum by means of ELISA test systems (a “sandwich” technique with peroxidase as an indicator enzyme). For statistical analysis, a multidimensional method was used, i.e., non-linear analysis of the principal components using the CATPCA algorithm. Among the children with CAP, our study revealed a consistent increase of IL-1ß, IL-4, IL-10, IL-2, TNFα, IFNλ2 (IL-28A), IFNλ3 (IL-28B), IL-8, MCP-1, IL-17AF, GM-CSF in blood serum. The highest correlation with severity was shown for IFNλ2 (IL-28A), IFNλ3 (IL-28B) and MCP-1, which may be considered additional biomarkers of the CAP severity. There was also a significant variability of the cytokine profile in healthy children and its significant skewing in pneumonia, especially in severe cases.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>внебольничная пневмония</kwd><kwd>дети</kwd><kwd>цитокиновый профиль</kwd><kwd>тяжелая внебольничная пневмония</kwd><kwd>метод CATPCA</kwd><kwd>биомаркеры пневмонии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>community-acquired pneumonia</kwd><kwd>children</kwd><kwd>cytokine profile</kwd><kwd>severe community-acquired pneumonia</kwd><kwd>CATPCA method</kwd><kwd>biomarkers of pneumonia</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Зайцева О.В. Формирование иммунитета: актуальные вопросы педиатрии // Аллергология и иммунология в педиатрии, 2014. Т. 2, № 37. С. 12-22.</mixed-citation><mixed-citation xml:lang="en">Zaitseva O.V. Formation of immunity: topical issues of pediatrics. Allergologiya i immunologiya v pediatrii = Allergology and Immunology in Pediatrics, 2014, Vol. 2, no. 37, pp. 12-22. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Изюрова Н.В., Савочкина А.Ю., Узунова А.Н., Нохрин Д.Ю. Цитокиновый профиль при внебольничной пневмонии у детей // Медицинская иммунология, 2022. Т. 24, № 5. С. 943-954. doi: 10.15789/1563-0625-CPI-2538.</mixed-citation><mixed-citation xml:lang="en">Izyurova N.V., Savochkina A.Yu., Uzunova A.N., Nokhrin D.Yu. Cytokine profile in community-acquired pneumonia in children. Meditsinskaya immunologiya = Medical Immunology (Russia), 2022, Vol. 24, no. 5, pp. 943-954. (In Russ.) doi: 10.15789/1563-0625-CPI-2538.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Пневмония (внебольничная). Оригинал-макет, 2022. 82 с.</mixed-citation><mixed-citation xml:lang="en">Pneumonia (community-acquired). Original layout, 2022. 82 p.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chen Y., Wang J., Liu C., Su L., Zhang D., Fan J., Yang Y., Xiao M., Xie J., Xu Y., Li Y., Zhang S. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med., 2020, Vol. 26, no. 1, 97. doi: 10.1186/s10020-020-00230-x.</mixed-citation><mixed-citation xml:lang="en">Chen Y., Wang J., Liu C., Su L., Zhang D., Fan J., Yang Y., Xiao M., Xie J., Xu Y., Li Y., Zhang S. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol. Med., 2020, Vol. 26, no. 1, 97. doi: 10.1186/s10020-020-00230-x.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chong Z., Karl C.E., Halfmann P.J., Kawaoka Y., Winkler E.S., Keeler S.P., Holtzman M.J., Yu J., Diamond M.S. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep., 2022, Vol. 39, no. 6, 110799. doi: 10.1016/j.celrep.2022.110799.</mixed-citation><mixed-citation xml:lang="en">Chong Z., Karl C.E., Halfmann P.J., Kawaoka Y., Winkler E.S., Keeler S.P., Holtzman M.J., Yu J., Diamond M.S. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron. Cell Rep., 2022, Vol. 39, no. 6, 110799. doi: 10.1016/j.celrep.2022.110799.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Gifi А. Nonlinear Multivariate Analysis. N.Y.: John Wiley &amp; Sons, 1990. 579 p.</mixed-citation><mixed-citation xml:lang="en">Gifi А. Nonlinear Multivariate Analysis. N.Y.: John Wiley &amp; Sons, 1990. 579 p.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hammer O., Harper D.A.T., Ryan P.D. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol. Electron., 2001, Vol. 4, Iss. 1, 4. Available at: http://palaeo-electronica.org/2001_1/past/issue1_01.htm.</mixed-citation><mixed-citation xml:lang="en">Hammer O., Harper D.A.T., Ryan P.D. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol. Electron., 2001, Vol. 4, Iss. 1, 4. Available at: http://palaeo-electronica.org/2001_1/past/issue1_01.htm.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Härtel C., Adam N., Strunk T., Temming P., Müller-Steinhardt M., Schultz C. Cytokine responses correlate differentially with age in infancy and early childhood. Clin. Exp. Immunol., 2005, Vol. 142, no. 3, pp. 446-453.</mixed-citation><mixed-citation xml:lang="en">Härtel C., Adam N., Strunk T., Temming P., Müller-Steinhardt M., Schultz C. Cytokine responses correlate differentially with age in infancy and early childhood. Clin. Exp. Immunol., 2005, Vol. 142, no. 3, pp. 446-453.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Haugen J., Chandyo R.K., Brokstad K.A., Mathisen M., Ulak M., Basnet S., Valentiner-Branth P., Strand T.A. Cytokine concentrations in plasma from children with severe and non-severe community acquired pneumonia. PLoS One, 2015, Vol. 10, no. 9, e0138978. doi: 10.1371/journal.pone.0138978.</mixed-citation><mixed-citation xml:lang="en">Haugen J., Chandyo R.K., Brokstad K.A., Mathisen M., Ulak M., Basnet S., Valentiner-Branth P., Strand T.A. Cytokine concentrations in plasma from children with severe and non-severe community acquired pneumonia. PLoS One, 2015, Vol. 10, no. 9, e0138978. doi: 10.1371/journal.pone.0138978.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Jeong S.D., Lee H., Chang J.Y., Lee S.Y., Choi J.E., Yang E., Jeong H.W., Choi J.P., Han M.S., Shin E.C. Increased type III interferons and NK cell functions in SARS-CoV-2-infected children. Signal Transduct. Target Ther., 2023, Vol. 8, no. 1, 54. doi: 10.1038/s41392-023-01340-8.</mixed-citation><mixed-citation xml:lang="en">Jeong S.D., Lee H., Chang J.Y., Lee S.Y., Choi J.E., Yang E., Jeong H.W., Choi J.P., Han M.S., Shin E.C. Increased type III interferons and NK cell functions in SARS-CoV-2-infected children. Signal Transduct. Target Ther., 2023, Vol. 8, no. 1, 54. doi: 10.1038/s41392-023-01340-8.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm., 2013, Vol. 2013, 434010. doi: 10.1155/2013/434010.</mixed-citation><mixed-citation xml:lang="en">Kleiner G, Marcuzzi A, Zanin V, Monasta L, Zauli G. Cytokine levels in the serum of healthy subjects. Mediators Inflamm., 2013, Vol. 2013, 434010. doi: 10.1155/2013/434010.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">le Roux D.M., Zar H.J. Community-acquired pneumonia in children – a changing spectrum of disease. Pediatr. Radiol., 2017, Vol. 47, no. 11, pp. 1392-1398.</mixed-citation><mixed-citation xml:lang="en">le Roux D.M., Zar H.J. Community-acquired pneumonia in children – a changing spectrum of disease. Pediatr. Radiol., 2017, Vol. 47, no. 11, pp. 1392-1398.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Li Y.T., Wang Y.C., Lee H.L., Tsao S.C., Lu M.C., Yang S.F. Monocyte chemoattractant protein-1, a possible biomarker of multiorgan failure and mortality in ventilator-associated pneumonia. Int. J. Mol. Sci., 2019, Vol. 20, no. 9, 2218. doi: 10.3390/ijms20092218.</mixed-citation><mixed-citation xml:lang="en">Li Y.T., Wang Y.C., Lee H.L., Tsao S.C., Lu M.C., Yang S.F. Monocyte chemoattractant protein-1, a possible biomarker of multiorgan failure and mortality in ventilator-associated pneumonia. Int. J. Mol. Sci., 2019, Vol. 20, no. 9, 2218. doi: 10.3390/ijms20092218.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Linting M., Meulman J.J., Groenen P.J., van der Koojj A.J. Nonlinear principal components analysis: introduction and application. Psychol. Methods, 2007, Vol. 12, no. 3, pp. 336-358.</mixed-citation><mixed-citation xml:lang="en">Linting M., Meulman J.J., Groenen P.J., van der Koojj A.J. Nonlinear principal components analysis: introduction and application. Psychol. Methods, 2007, Vol. 12, no. 3, pp. 336-358.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Lu Q., Zhu Z., Tan C., Zhou H., Hu Y., Shen G., Zhu P., Yang G., Xie X. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int. J. Clin. Pract., 2021, Vol. 75, no. 9, e14462. doi: 10.1111/ijcp.14462.</mixed-citation><mixed-citation xml:lang="en">Lu Q., Zhu Z., Tan C., Zhou H., Hu Y., Shen G., Zhu P., Yang G., Xie X. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients. Int. J. Clin. Pract., 2021, Vol. 75, no. 9, e14462. doi: 10.1111/ijcp.14462.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">McGuinness D., Bennett S., Riley E. Statistical analysis of highly skewed immune response data. J. Immunol. Methods, 1997, Vol. 201, no. 1, pp. 99-114.</mixed-citation><mixed-citation xml:lang="en">McGuinness D., Bennett S., Riley E. Statistical analysis of highly skewed immune response data. J. Immunol. Methods, 1997, Vol. 201, no. 1, pp. 99-114.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Michailidis G., de Leeuw J. The gifi system of descriptive multivariate analysis. Stat. Sci., 1998, Vol. 13, no. 4, pp. 307-336.</mixed-citation><mixed-citation xml:lang="en">Michailidis G., de Leeuw J. The gifi system of descriptive multivariate analysis. Stat. Sci., 1998, Vol. 13, no. 4, pp. 307-336.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Nandi A., Bishayi B. Murine macrophage response from peritoneal cavity requires signals mediated by chemokine receptor CCR-2 during Staphylococcus aureus infection. Immunol. Res., 2016, Vol. 64, no. 1, pp. 213-232.</mixed-citation><mixed-citation xml:lang="en">Nandi A., Bishayi B. Murine macrophage response from peritoneal cavity requires signals mediated by chemokine receptor CCR-2 during Staphylococcus aureus infection. Immunol. Res., 2016, Vol. 64, no. 1, pp. 213-232.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Nascimento-Carvalho E.C., Vasconcellos Â.G., Clarêncio J., Andrade D., Barral A., Barral-Netto M., Nascimento-Carvalho C.M. Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies. Pediatr. Pulmonol., 2020, Vol. 55, no. 1, pp. 169-176.</mixed-citation><mixed-citation xml:lang="en">Nascimento-Carvalho E.C., Vasconcellos Â.G., Clarêncio J., Andrade D., Barral A., Barral-Netto M., Nascimento-Carvalho C.M. Evolution of cytokines/chemokines in cases with community-acquired pneumonia and distinct etiologies. Pediatr. Pulmonol., 2020, Vol. 55, no. 1, pp. 169-176.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Raman D., Sobolik-Delmaire T., Richmond A. Chemokines in health and disease. Exp. Cell Res., 2011, Vol. 317, no. 5, pp. 575-589.</mixed-citation><mixed-citation xml:lang="en">Raman D., Sobolik-Delmaire T., Richmond A. Chemokines in health and disease. Exp. Cell Res., 2011, Vol. 317, no. 5, pp. 575-589.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Rendon A., Rendon-Ramirez E.J., Rosas-Taraco A.G. Relevant cytokines in the management of community-acquired pneumonia. Curr. Infect. Dis. Rep., 2016, Vol. 18, no. 3, 10. doi: 10.1007/s11908-016-0516-y.</mixed-citation><mixed-citation xml:lang="en">Rendon A., Rendon-Ramirez E.J., Rosas-Taraco A.G. Relevant cytokines in the management of community-acquired pneumonia. Curr. Infect. Dis. Rep., 2016, Vol. 18, no. 3, 10. doi: 10.1007/s11908-016-0516-y.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Reverberi R. The statistical analysis of immunohaematological data. Blood Transfus., 2008, Vol. 6, no. 1, pp. 37-45.</mixed-citation><mixed-citation xml:lang="en">Reverberi R. The statistical analysis of immunohaematological data. Blood Transfus., 2008, Vol. 6, no. 1, pp. 37-45.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Siljan W.W., Holter J.C., Nymo S.H., Husebye E., Ueland T., Aukrust P., Mollnes T.E., Heggelund L. Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia. Eur. J. Clin. Invest., 2018, Vol. 48, no. 1, e12865. doi: 10.1111/eci.12865.</mixed-citation><mixed-citation xml:lang="en">Siljan W.W., Holter J.C., Nymo S.H., Husebye E., Ueland T., Aukrust P., Mollnes T.E., Heggelund L. Cytokine responses, microbial aetiology and short-term outcome in community-acquired pneumonia. Eur. J. Clin. Invest., 2018, Vol. 48, no. 1, e12865. doi: 10.1111/eci.12865.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Sposito B., Broggi A., Pandolfi L., Crotta S., Clementi N., Ferrarese R., Sisti S., Criscuolo E., Spreafico R., Long J.M., Ambrosi A., Liu E., Frangipane V., Saracino L., Bozzini S., Marongiu L., Facchini F.A., Bottazzi A., Fossali T., Colombo R., Clementi M., Tagliabue E., Chou J., Pontiroli A.E., Meloni F., Wack A., Mancini N., Zanoni I. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell, 2021, Vol. 184, no. 19, pp. 4953-4968.e16.</mixed-citation><mixed-citation xml:lang="en">Sposito B., Broggi A., Pandolfi L., Crotta S., Clementi N., Ferrarese R., Sisti S., Criscuolo E., Spreafico R., Long J.M., Ambrosi A., Liu E., Frangipane V., Saracino L., Bozzini S., Marongiu L., Facchini F.A., Bottazzi A., Fossali T., Colombo R., Clementi M., Tagliabue E., Chou J., Pontiroli A.E., Meloni F., Wack A., Mancini N., Zanoni I. The interferon landscape along the respiratory tract impacts the severity of COVID-19. Cell, 2021, Vol. 184, no. 19, pp. 4953-4968.e16.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Stanifer M.L., Guo C., Doldan P., Boulant S. Importance of Type I and III interferons at respiratory and intestinal barrier surfaces. Front. Immunol., 2020, Vol. 11, 608645. doi: 10.3389/fimmu.2020.60864.</mixed-citation><mixed-citation xml:lang="en">Stanifer M.L., Guo C., Doldan P., Boulant S. Importance of Type I and III interferons at respiratory and intestinal barrier surfaces. Front. Immunol., 2020, Vol. 11, 608645. doi: 10.3389/fimmu.2020.60864.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Vasconcellos Â.G., Clarêncio J., Andrade D., Araújo-Neto C.A., Barral A., Nascimento-Carvalho C.M. Systemic cytokines/chemokines associated to radiographic abnormalities in pneumonia in children. Cytokine, 2020, Vol. 135, 155191. doi: 10.1016/j.cyto.2020.155191.</mixed-citation><mixed-citation xml:lang="en">Vasconcellos Â.G., Clarêncio J., Andrade D., Araújo-Neto C.A., Barral A., Nascimento-Carvalho C.M. Systemic cytokines/chemokines associated to radiographic abnormalities in pneumonia in children. Cytokine, 2020, Vol. 135, 155191. doi: 10.1016/j.cyto.2020.155191.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Yong K.K., Chang J.H., Chien M.H., Tsao S.M., Yu M.C., Bai K.J., Tsao T.C., Yang S.F. Plasma monocyte chemoattractant protein-1 level as a predictor of the severity of community-acquired pneumonia. Int. J. Mol. Sci., 2016, Vol. 17, no. 2, 179. doi: 10.3390/ijms17020179.</mixed-citation><mixed-citation xml:lang="en">Yong K.K., Chang J.H., Chien M.H., Tsao S.M., Yu M.C., Bai K.J., Tsao T.C., Yang S.F. Plasma monocyte chemoattractant protein-1 level as a predictor of the severity of community-acquired pneumonia. Int. J. Mol. Sci., 2016, Vol. 17, no. 2, 179. doi: 10.3390/ijms17020179.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
